INBRAIN Neuroelectronics raised $50M in a Series B funding led by imec.xpand to advance their graphene-based brain-computer interface technology.
Amount Raised
$50 Million
Round Type
Series B
BarcelonaBiotechnologyTherapeuticsInvestors
Description
INBRAIN Neuroelectronics has announced the closure of a Series B funding round of $50 million led by imec.xpand, with participation from EIC Fund and others. This funding will accelerate the development of their BCI-Tx platform and expand its applications in therapeutic areas.
Quick answer
INBRAIN Neuroelectronics raised $50 Million in a Series B round, dated October 29, 2024. Investors: Aliath Bioventures, Asabys Partners, Avançsa, Vsquared, EIC Fund, Fond Ico Next Tech, CDTI Innvierte and Imec.Xpand. INBRAIN Neuroelectronics is based in Barcelona, Catalonia, Spain.
- How much did INBRAIN Neuroelectronics raise?
- INBRAIN Neuroelectronics raised $50 Million in a Series B round on October 29, 2024.
- Who invested in INBRAIN Neuroelectronics?
- Aliath Bioventures, Asabys Partners, Avançsa, Vsquared, EIC Fund, Fond Ico Next Tech, CDTI Innvierte and Imec.Xpand are named as investors in this round.
- What does INBRAIN Neuroelectronics do?
- INBRAIN Neuroelectronics is a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies with a focus on precision neurology.
- Where is INBRAIN Neuroelectronics based and how big is it?
- INBRAIN Neuroelectronics is based in Barcelona, Catalonia, Spain. Fundz records about 65 employees.
- Who are the decision-makers at INBRAIN Neuroelectronics?
- Fundz holds 1 contact at INBRAIN Neuroelectronics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as INBRAIN Neuroelectronics that raised within 45 days of this round, from Fundz verified event records.
- BioSapien raised $5.5M (Series A) on December 13, 2024.
- Noema Pharma raised $147M (Series B) on December 11, 2024.
- Angitia Biopharmaceuticals raised $120M (Series C) on December 11, 2024.
- East Ocyon Bio raised $4.2M (Seed) on December 11, 2024.
- Canton Strategic Holdings, Inc. raised $2M (Seed) on December 9, 2024.
- Alveron Pharma raised $5.3M (Seed) on December 6, 2024.
Who to call at INBRAIN Neuroelectronics, and when
A new round usually means INBRAIN Neuroelectronics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day INBRAIN Neuroelectronics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at INBRAIN Neuroelectronics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at INBRAIN Neuroelectronics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment INBRAIN Neuroelectronics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansINBRAIN Neuroelectronics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.